Serum samples, collected at the mother's first visit to maternity care, were obtained from the national Finnish Maternity Cohort biobank. Biomarkers of alcohol consumption - gamma-glutamyltransferase (GGT), carbohydrate-deficient transferrin (CDT), a combination of GGT and CDT (GGT-CDT), and ethylglucuronide (EtG) - were analyzed from the blood of mothers of 385 FAS cases and 745 non-FAS controls.
‘Testing for alcohol biomarkers during the first trimester may help to identify pregnancies that are high risk for fetal alcohol syndrome (FAS).’
The authors found that median levels of all biomarkers were significantly higher among the mothers of FAS children than in the control mothers. Nearly half (46%) of the mothers with affected offspring could be identified based on the biomarker data. The predictive association was highest for the GGT-CDT combination. The researchers suggest that testing for alcohol biomarkers during the first trimester may help to identify pregnancies that are high risk for FAS.
Source: Newswise